公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2022 | Factors Associated with Significant Platelet Count Improvement in Thrombocytopenic Chronic Hepatitis C Patients Receiving Direct-Acting Antivirals | Chen Y.-C.; Chang T.-S.; Chen C.-H.; Cheng P.-N.; Lo C.-C.; Mo L.-R.; Chen C.-T.; Huang C.-F.; Kuo H.-T.; Huang Y.-H.; Tai C.-M.; Peng C.-Y.; Bair M.-J.; Yeh M.-L.; Lin C.-L.; Lin C.-Y.; Lee P.-L.; Chong L.-W.; Hung C.-H.; Huang J.-F.; Yang C.-C.; Hu J.-T.; Lin C.-W.; Wang C.-C.; Su W.-W.; Hsieh T.-Y.; Lin C.-L.; Tsai W.-L.; Lee T.-H.; Chen G.-Y.; Wang S.-J.; Chang C.-C.; Yang S.-S.; Wu W.-C.; Huang C.-S.; Hsiung C.-K.; Kao C.-N.; Tsai P.-C.; CHEN-HUA LIU ; Lee M.-H.; Dai C.-Y.; JIA-HORNG KAO ; Chuang W.-L.; Lin H.-C.; Chen C.-Y.; Tseng K.-C.; Yu M.-L.; on behalf of TACR investigators | Viruses | 1 | 1 | |
2021 | Factors associated with treatment failure of direct-acting antivirals for chronic hepatitis C: A real-world nationwide hepatitis C virus registry programme in Taiwan | Chen C.-Y.; Huang C.-F.; Cheng P.-N.; Tseng K.-C.; Lo C.-C.; Kuo H.-T.; Huang Y.-H.; Tai C.-M.; Peng C.-Y.; Bair M.-J.; Chen C.-H.; Yeh M.-L.; Lin C.-L.; Lin C.-Y.; Lee P.-L.; Chong L.-W.; Hung C.-H.; Huang J.-F.; Yang C.-C.; Hu J.-T.; Lin C.-W.; Chen C.-T.; Wang C.-C.; Su W.-W.; Hsieh T.-Y.; Lin C.-L.; Tsai W.-L.; Lee T.-H.; Chen G.-Y.; Wang S.-J.; Chang C.-C.; Mo L.-R.; Yang S.-S.; Wu W.-C.; Huang C.-S.; Hsiung C.-K.; Kao C.-N.; Tsai P.-C.; CHEN-HUA LIU ; Lee M.-H.; CHUN-JEN LIU ; Dai C.-Y.; JIA-HORNG KAO ; Chuang W.-L.; Lin H.-C.; Yu M.-L. | Liver International | 25 | 23 | |
2020 | Factors predicting outcomes of hepatitis B-related cirrhosis patients with long-term antiviral therapy | Lin C.-L.; Tseng K.-C.; Chen K.-Y.; Liao L.-Y.; JIA-HORNG KAO | Journal of the Formosan Medical Association | 5 | 5 | |
2008 | Fatal meningitis caused by Mycobacterium nonchromogenicum in a patient with nasopharyngeal carcinoma | Lai C.-C.; Chen H.-W.; Liu W.-L.; Ding L.-W.; Lin C.-L.; Lu G.-D.; PO-REN HSUEH | Clinical Infectious Diseases | 7 | 4 | |
2015 | Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients | Wang C.-C.; CHEN-HUA LIU ; Lin C.-L.; Wang P.-C.; TAI-CHUNG TSENG ; Lin H.H.; JIA-HORNG KAO | Journal of the Formosan Medical Association | 27 | 27 | |
2022 | First Demonstration of Heterogeneous IGZO/Si CFET Monolithic 3-D Integration With Dual Work Function Gate for Ultralow-Power SRAM and RF Applications | Chang S.-W.; Lu T.-H.; Yang C.-Y.; Yeh C.-J.; Huang M.-K; Meng C.-F.; Chen P.-J.; Chang T.-H.; Chang Y.-S.; Jhu J.-W.; Hong T.-C.; Ke C.-C.; Yu X.-R.; Lu W.-H.; Baig M.A.; Cho T.-C.; Sung P.-J.; Su C.-J.; Hsueh F.-K.; Chen B.-Y.; Hu H.-H.; Wu C.-T.; Lin K.-L.; Ma W.C.-Y.; Lu D.D.; Kao K.-H.; Lee Y.-J.; Lin C.-L.; Huang K.-P.; Chen K.-M.; Li Y.; Samukawa S.; Chao T.-S.; Huang G.-W.; Wu W.-F.; Lee W.-H.; JIUN-YUN LI ; Shieh J.-M.; Tarng J.-H.; Wang Y.-H.; Yeh W.-K. | IEEE Transactions on Electron Devices | 9 | 6 | |
2020 | First demonstration of heterogenous complementary FETs utilizing Low-Temperature (200 °c) Hetero-Layers Bonding Technique (LT-HBT) | Hong T.-Z.; Chang W.-H.; Agarwal A.; Huang Y.-T.; Yang C.-Y.; Chu T.-Y.; Chao H.-Y.; Chuang Y.; Chung S.-T.; Lin J.-H.; Luo S.-M.; Tsai C.-J.; Li M.-J.; Yu X.-R.; Lin N.-C.; Cho T.-C.; Sung P.-J.; Su C.-J.; Luo G.-L.; Hsueh F.-K.; Lin K.-L.; Ishii H.; Irisawa T.; Maeda T.; Wu C.-T.; Ma W.C.-Y.; Lu D.-D.; Kao K.-H.; Lee Y.-J.; Chen H.J.-H.; Lin C.-L.; Chuang R.W.; Huang K.-P.; Samukawa S.; Li Y.-M.; Tarng J.-H.; Chao T.-S.; Miura M.; Huang G.-W.; Wu W.-F.; JIUN-YUN LI ; Shieh J.-M.; Wang Y.-H.; Yeh W.-K. | Technical Digest - International Electron Devices Meeting, IEDM | 8 | 0 | |
2016 | Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients | TUNG-HUNG SU ; Hu T.-H.; Chen C.-Y.; Huang Y.-H.; Chuang W.-L.; Lin C.-C.; Wang C.-C.; Su W.-W.; Chen M.-Y.; Peng C.-Y.; Chien R.-N.; Huang Y.-W.; Wang H.-Y.; Lin C.-L.; Yang S.-S.; Chen T.-M.; Mo L.-R.; SHIH-JER HSU ; Tseng K.-C.; Hsieh T.-Y.; Suk F.-M.; Hu C.-T.; Bair M.-J.; Liang C.-C.; Lei Y.-C.; TAI-CHUNG TSENG ; CHI-LING CHEN ; JIA-HORNG KAO ; the C-TEAM study group; the Taiwan Liver Diseases Consortium | Liver International | 165 | 149 | |
2008 | Free fatty acids act as endogenous ionophores, resulting in Na+ and Ca2+ influx and myocyte apoptosis | Fang K.-M.; Lee A.-S.; MING-JAI SU ; Lin C.-L.; CHUNG-LIANG CHIEN ; Wu M.-L. | Cardiovascular Research | 35 | 30 | |
2012 | Functional dissection of lysine deacetylases reveals that HDAC1 and p300 regulate AMPK | Lin Y.-Y.; Kiihl S.; Suhail Y.; Liu S.-Y.; Chou Y.-H.; Kuang Z.; JIN-YING LU ; Khor C.N.; Lin C.-L.; Bader J.S.; Irizarry R.; Boeke J.D. | Nature | 77 | 73 | |
2013 | Genetic variation-optimized treatment benefit of angiotensin-converting enzyme inhibitors in patients with stable coronary artery disease: A 12-year follow-up study | JEN-KUANG LEE ; CHO-KAI WU ; CHIA-TI TSAI ; LIAN-YU LIN ; JOU-WEI LIN ; KUO-LIONG CHIEN ; HWANG, JUEY-JEN ; Lin C.-L.; Tseng C.-D.; FU-TIEN CHIANG | Pharmacogenetics and Genomics | 7 | 5 | |
2017 | Genome-wide identification of blood DNA methylation patterns associated with early-onset hepatocellular carcinoma development in hepatitis B carriers | Kao W.-Y.; Yang S.-H.; Liu W.-J.; Yeh M.-Y.; Lin C.-L.; CHUN-JEN LIU ; Huang C.-J.; Lin S.-M.; Lee S.-D.; PEI-JER CHEN ; MING-WHEI YU | Molecular Carcinogenesis | 20 | 16 | |
2016 | Glycemic control and adherence to basal insulin therapy in Taiwanese patients with type 2 diabetes mellitus | Chien M.-N.; Chen Y.-L.; Hung Y.-J.; Wang S.-Y.; Lu W.-T.; Chen C.-H.; Lin C.-L.; Huang T.-P.; Tsai M.-H.; Tseng W.-K.; Wu T.-J.; Ho C.; Lin W.-Y.; Chen B.; LEE-MING CHUANG | Journal of Diabetes Investigation | 10 | 10 | |
2021 | Harnessing the Inductive Effect to Design New Donor-Acceptor-Acceptor′-Configured Small-Molecule Donors for Vacuum-Processed Organic Photovoltaics | Chen C.-H.; Chen C.-J.; Chen Y.-A.; Chang Y.-H.; Liu H.-C.; Lo Y.-C.; Lin B.-Y.; Lin C.-L.; Easley C.J.; Bardeen C.J.; Chen Y.-S.; JIUN-HAW LEE ; Chiu T.-L.; KEN-TSUNG WONG | Energy and Fuels | 2 | 1 | |
2009 | HBV genotypes and chronicification of acute hepatitis B: More questions than answers | Lin C.-L.; JIA-HORNG KAO | Gut | 1 | 0 | |
2015 | HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients | Peng C.-Y.; Hsieh T.-C.; Hsieh T.-Y.; Tseng K.-C.; Lin C.-L.; TUNG-HUNG SU ; TAI-CHUNG TSENG ; Lin H.H.; Wang C.-C.; JIA-HORNG KAO | Journal of the Formosan Medical Association | 12 | 11 | |
2021 | Hepatic steatosis and development of type 2 diabetes: Impact of chronic hepatitis B and viral specific factors | MING-WHEI YU ; Lin C.-L.; CHUN-JEN LIU ; Huang Y.-W.; Hu J.-T.; Wu W.-J.; Wu C.-F. | Journal of the Formosan Medical Association | 9 | 7 | |
2002 | Hepatitis B genotypes and precore/basal core promoter mutants in HBeAg-negative chronic hepatitis B | Lin C.-L.; Liao L.-Y.; CHUN-JEN LIU ; PEI-JER CHEN ; Lai M.-Y.; JIA-HORNG KAO ; DING-SHINN CHEN | Journal of Gastroenterology | 37 | 37 | |
2017 | Hepatitis B reactivation in patients receiving immunosuppressive therapy: a hidden menace | Lin C.-L.; JIA-HORNG KAO | Hepatology International | 2 | 2 | |
2011 | Hepatitis B viraemia: Its heritability and association with common genetic variation in the interferon γ signalling pathway | Huang H.-H.; WEI-LIANG SHIH ; Li Y.-H.; Wu C.-F.; PEI-JER CHEN ; Lin C.-L.; CHUN-JEN LIU ; Liaw Y.-F.; Lin S.-M.; Lee S.-D.; MING-WHEI YU | Gut | 23 | 23 |